Renal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Renal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: A Phase II Study of Cyberknife Radiosurgery for Renal Cell Carcinoma [NA]
A Phase II study of CyberKnife radiosurgery for renal cell carcinoma is currently recruiting at Beth Israel Deaconess Medical Center.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Trial of X4P-001 in Participants With Advanced Renal Cell Carcinoma [Phase 1, Phase 2]
Results from a Phase 1/2 trial of X4P-001 in participants with advanced renal cell carcinoma have been posted. The study includes the clear …
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer [Phase 2]
Phase 2 neoadjuvant trial of cabozantinib for locally advanced renal cell carcinoma has posted results. The study includes patients with cle…
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Retrospective Analysis of Patients With Metastatic Renal Cell Carcinoma Treated With CABOzantinib
A ClinicalTrials.gov listing notes a retrospective analysis of patients with metastatic renal cell carcinoma treated with CABOzantinib, curr…
-
CLINICAL_TRIALS trial_result · 2024-08-09Clinical Trial Update: Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
A Mayo Clinic-sponsored clinical trial investigating immunophenotyping in patients with metastatic renal cell carcinoma undergoing ablative …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-08-06FDA Approved: FOTIVDA — Supplemental Application (AVEO Pharmaceuticals, Inc.)
FDA approved a supplemental application for Fotivda (tivozanib) submitted by AVEO Pharmaceuticals, Inc.
-
CLINICAL_TRIALS research · 2024-08-06Clinical Trial Update: Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients
A completed study evaluating risk-based screening and prognostic factors for second primary malignancies in kidney cancer patients.
-
CLINICAL_TRIALS trial_result · 2024-08-05Clinical Trial Update: A Study to go Back Into Records and Observe How People With Metastatic Renal Cell Carcinoma (mRCC) Who Received a Medicine Called Sunitinib Responded to This Medicine.
This clinical trial update summarizes outcomes observed in patients with metastatic renal cell carcinoma treated with sunitinib, based on re…
-
CLINICAL_TRIALS trial_result · 2024-08-02Clinical Trial Update: Multiparametric MRI for Diagnosing Small Renal Tumors [NA]
This document reports the completion of a clinical trial evaluating multiparametric MRI as a diagnostic tool for small renal tumors.
-
CLINICAL_TRIALS withdrawal · 2024-08-02Clinical Trial Update: Impact of Perioperative Anesthetic Management on Renal Cancer Progression.
The clinical trial investigating the impact of perioperative anesthetic management on renal cancer progression has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-07-29Clinical Trial Update: Study to Test the Safety and Tolerability of PF-07209960 in Advanced or Metastatic Solid Tumors [Phase 1]
Phase 1 study of PF-07209960 in advanced or metastatic solid tumors was terminated, with results posted in July 2024.
-
CLINICAL_TRIALS trial_result · 2024-07-26Clinical Trial Update: Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy [Phase 2]
Phase 2 clinical trial evaluating vorolanib in combination with sintilimab for advanced renal cell carcinoma after prior immune checkpoint i…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Ultrasound Elastography Combined With Conventional Mri in Differentiating Solid Renal Parenchyma Masses
This clinical trial evaluates whether ultrasound elastography combined with conventional MRI improves differentiation of solid renal parench…
-
CLINICAL_TRIALS research · 2024-07-23Clinical Trial Update: Anesthesia and Cancer Study: Renal Cell Carcinoma [NA]
Clinical trial update for the anesthesia and cancer study focused on renal cell carcinoma; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies [Phase 2]
Phase 2 trial update for Zirconium-89 labeled Crefmirlimab Berdoxam PET/CT in advanced or metastatic cancers; the study is currently active …
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: Treatment Patterns With Targeted Therapies In Mrcc In Sweden - A Retrospective Analysis Of Data From National Registries
Pfizer-sponsored retrospective analysis of Swedish national registry data assessing treatment patterns with targeted therapies for metastati…
-
CLINICAL_TRIALS trial_result · 2024-07-17Clinical Trial Update: SAbR For Oligo-Progressive Renal Cell Cancer. [Phase 2]
A Phase 2 clinical trial evaluating stereotactic ablative radiotherapy for oligoprogressive renal cell carcinoma has completed.
-
FDA approval · 2024-07-16FDA Approved: INLYTA — Supplemental Application (U.S. Pharmaceuticals)
The FDA has approved a supplemental application for INLYTA (axitinib) submitted by U.S. Pharmaceuticals.
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Dexamethasone Versus Mg Added to Bupivacaine Used in ESPB for Perioperative Pain Control in Patients Undergoing Unilateral Nephrectomy [NA]
This clinical trial is evaluating whether dexamethasone or magnesium added to bupivacaine in an erector spinae plane block improves perioper…
-
CLINICAL_TRIALS trial_result · 2024-07-09Clinical Trial Update: Study of RO7515629 in Participants With HLA-G Positive Solid Tumors [Phase 1]
This Phase 1 study of RO7515629 in participants with HLA-G positive solid tumors has been terminated. The trial enrolled patients with renal…
-
CLINICAL_TRIALS research · 2024-07-09Clinical Trial Update: A Study of JMKX003948 Tablets in Patients With Renal Cell Carcinoma [Phase 1]
Phase 1 trial of JMKX003948 tablets in metastatic renal cell carcinoma is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC) [Phase 1]
This Phase 1 trial update reports results for combining cabozantinib (Cabometyx) with avelumab in patients with metastatic renal cell carcin…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: CBM588, Nivolumab, and Ipilimumab in Treating Patients With Stage IV or Advanced Kidney Cancer [Phase 1]
This Phase 1 trial evaluates CBM588 in combination with nivolumab and ipilimumab for advanced or stage IV renal cell carcinoma; the study ha…
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: GRADE-SRM: Genomic Risk Assessment and Decisional Evaluation for Small Renal Masses [NA]
A UNC Lineberger Comprehensive Cancer Center-sponsored trial evaluating Genomic Risk Assessment and Decisional Evaluation for Small Renal Ma…
-
CLINICAL_TRIALS research · 2024-07-01Clinical Trial Update: Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance
An update on a cancer research trial involving collection of blood, bone marrow, tumor, or tissue samples from patients to study drug resist…